{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:27:39Z","timestamp":1791235659175,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017024","name":"Salah Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.oret.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T05:02:31Z","timestamp":1602306151000},"page":"648-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dose-Response Relationship between Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"5","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarup S.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3371-9551","authenticated-orcid":false,"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Barikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1336-1695","authenticated-orcid":false,"given":"Mengxi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Feuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2020.10.004_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.10.004_bib2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.ophtha.2015.08.009","article-title":"Prospective trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: TREX-AMD 1-year results","volume":"122","author":"Wykoff","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.10.004_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular morphology and visual acuity in year five of the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.10.004_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2017.0059","article-title":"Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery","volume":"135","author":"Eadie","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12886-016-0255-8","article-title":"Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/IAE.0b013e3180592ba6","article-title":"Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin)","volume":"27","author":"Falkenstein","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.oret.2020.10.004_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ajo.2008.07.007","article-title":"Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents","volume":"146","author":"Kim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.10.004_bib9","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1523\/JNEUROSCI.19-14-05731.1999","article-title":"Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system","volume":"19","author":"Sondell","year":"1999","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.oret.2020.10.004_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.oret.2020.10.004_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.oret.2020.10.004_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/IJG.0b013e31820d7d19","article-title":"Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"21","author":"Tseng","year":"2012","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.oret.2020.10.004_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00417-012-1981-0","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration","volume":"250","author":"Mathalone","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents","volume":"95","author":"Good","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib15","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1167\/iovs.12-9875","article-title":"Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab","volume":"53","author":"Martinez-de-la-Casa","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.10.004_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10792-014-9972-2","article-title":"The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degeneration","volume":"35","author":"Parlak","year":"2015","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib17","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1167\/iovs.15-18404","article-title":"Intravitreal anti-vascular endothelial growth factor therapy and retinal nerve fiber layer loss in eyes with age-related macular degeneration: a meta-analysis","volume":"57","author":"Shin","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.10.004_bib18","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00417-019-04325-y","article-title":"Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degeneration","volume":"257","author":"Valverde-Megias","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/02713683.2014.917190","article-title":"The effect of multiple injections of ranibizumab on retinal nerve fiber layer thickness in patients with age-related macular degeneration","volume":"40","author":"Demirel","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2020.10.004_bib20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ajo.2010.04.029","article-title":"Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy","volume":"150","author":"Horsley","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170271","article-title":"Assessment of corneal sensation, innervation and retinal nerve fiber layer in patients treated with multiple intravitreal ranibizumab injections","volume":"12","author":"Bitirgen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2020.10.004_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3341\/kjo.2016.30.2.114","article-title":"Longitudinal changes in retinal nerve fiber layer thickness after intravitreal anti-vascular endothelial growth factor therapy","volume":"30","author":"Jo","year":"2016","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib23","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s10792-019-01116-6","article-title":"Long-term changes in retinal layers in patients undergoing intravitreal ranibizumab for neovascular age-related macular degeneration: retinal layers after anti-VEGF therapy","volume":"39","author":"Inan","year":"2019","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib24","first-page":"211","article-title":"Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure: a comparative clinical study","volume":"6","author":"Sobaci","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/jop.2016.0014","article-title":"Retinal nerve fiber layer thickness changes in age-related macular degeneration treated with multiple intravitreal ranibizumab","volume":"32","author":"Sengul","year":"2016","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2020.10.004_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ajo.2010.09.015","article-title":"Interocular symmetry in peripapillary retinal nerve fiber layer thickness measured with the Cirrus HD-OCT in healthy eyes","volume":"151","author":"Mwanza","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/02713680600646882","article-title":"The effect of phacoemulsification cataract surgery on the measurement of retinal nerve fiber layer thickness using optical coherence tomography","volume":"31","author":"El-Ashry","year":"2006","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2020.10.004_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IJG.0b013e3181ccb93b","article-title":"Effect of cataract and its removal on signal strength and peripapillary retinal nerve fiber layer optical coherence tomography measurements","volume":"20","author":"Mwanza","year":"2011","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.oret.2020.10.004_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1442-9071.2010.02460.x","article-title":"Comparison of the influence of cataract and pupil size on retinal nerve fibre layer thickness measurements with time-domain and spectral-domain optical coherence tomography","volume":"39","author":"Cheng","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.04.003","article-title":"Retinal ganglion cell layer change in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"167","author":"Beck","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcjo.2015.01.008","article-title":"Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration","volume":"50","author":"Yau","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajo.2015.05.030","article-title":"Macular ganglion cell complex and retinal nerve fiber layer comparison in different stages of age-related macular degeneration","volume":"160","author":"Zucchiatti","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib33","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1167\/iovs.15-17013","article-title":"Ganglion cell-inner plexiform layer and peripapillary retinal nerve fiber layer thicknesses in age-related macular degeneration","volume":"56","author":"Lee","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.10.004_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/eye.2015.48","article-title":"Defining response to anti-VEGF therapies in neovascular AMD","volume":"29","author":"Amoaku","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2020.10.004_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2017.07.014","article-title":"Treat-and-extend versus monthly regimen in neovascular age-related macular degeneration: results with ranibizumab from the TREND Study","volume":"125","author":"Silva","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.10.004_bib36","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00417-019-04404-0","article-title":"Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study","volume":"257","author":"Augsburger","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/IJG.0b013e318294865c","article-title":"Ocular decompression with cotton swabs lowers intraocular pressure elevation after intravitreal injection","volume":"23","author":"Gregori","year":"2014","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.oret.2020.10.004_bib38","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archophthalmol.2010.297","article-title":"Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections","volume":"128","author":"Frenkel","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2020.10.004_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40942-019-0157-z","article-title":"Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects","volume":"5","author":"Saxena","year":"2019","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2020.10.004_bib40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the Randomized Phase 2 Ladder Clinical Trial","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.10.004_bib41","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1167\/iovs.10-5222","article-title":"Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HD-OCT in glaucomatous eyes","volume":"51","author":"Mwanza","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.10.004_bib42","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/02713683.2019.1610179","article-title":"Anti-vascular endothelial growth factor intravitreal therapy and macular ganglion cell layer thickness in patients with neovascular age-related macular degeneration","volume":"44","author":"Abdolrahimzadeh","year":"2019","journal-title":"Curr Eye Res"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020304097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020304097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:29:16Z","timestamp":1762853356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653020304097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2468653020304097"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2020.10.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-Response Relationship between Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}